LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30139% above fair value
$14.08−0.07 (-0.49%)
Close on Nov 13, 2026Market cap $5.38BP/E 74.1Yield –
LifeStance Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
LifeStance Health's operating cash flow for the twelve months ending Sep 30, 2026 was $227.60M, up 50.8% year over year. For fiscal 2025 it was $146.15M, up 36.3% from the year before. The highest annual figure on record is $146.15M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $146.15M | +36.3% |
| FY2024 | Dec 31, 2024 | $107.26M | – |
| FY2023 | Dec 31, 2023 | -$16.88M | -132.0% |
| FY2022 | Dec 31, 2022 | $52.79M | +460.4% |
| FY2021 | Dec 31, 2021 | $9.42M | -44.7% |
| FY2019 | Dec 31, 2019 | $17.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $37.02M | +35.7% |
| Q2 FY2026 | Jun 30, 2026 | $99.91M | +55.2% |
| Q1 FY2026 | Mar 31, 2026 | $33.11M | – |
| Q4 FY2025 | Dec 31, 2025 | $57.56M | -7.6% |
| Q3 FY2025 | Sep 30, 2025 | $27.29M | +20.1% |
| Q2 FY2025 | Jun 30, 2025 | $64.40M | +46.2% |
| Q1 FY2025 | Mar 31, 2025 | -$3.09M | – |
| Q4 FY2024 | Dec 31, 2024 | $62.32M | +271.0% |
| Q3 FY2024 | Sep 30, 2024 | $22.72M | – |
| Q2 FY2024 | Jun 30, 2024 | $44.06M | – |
| Q1 FY2024 | Mar 31, 2024 | -$21.84M | – |
| Q4 FY2023 | Dec 31, 2023 | $16.80M | -53.2% |
| Q3 FY2023 | Sep 30, 2023 | -$25.36M | -542.5% |
| Q2 FY2023 | Jun 30, 2023 | -$434.00K | -105.5% |
| Q1 FY2023 | Mar 31, 2023 | -$7.89M | -338.5% |
| Q4 FY2022 | Dec 31, 2022 | $35.92M | +17.2% |
| Q3 FY2022 | Sep 30, 2022 | $5.73M | – |
| Q2 FY2022 | Jun 30, 2022 | $7.83M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.31M | -66.6% |
| Q4 FY2021 | Dec 31, 2021 | $30.64M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.21M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.92M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.91M | – |
| Q2 FY2020 | Jun 30, 2020 | -$37.32M | – |
See a number that looks wrong?